Medicare Enrolled

Dr. Mahjabeen Haq, D.O.

Rheumatology · Babylon, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
500 W MAIN ST STE 110, Babylon, NY 11702
6313762663
In practice since 2013 (13 years)
NPI: 1790123289 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haq from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haq? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Haq

Dr. Mahjabeen Haq is a rheumatology specialist in Babylon, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Haq performed 27,876 Medicare services across 1,435 unique beneficiaries.

Between the years covered by Open Payments, Dr. Haq received a total of $16,265 from 39 pharmaceutical and/or device companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Haq is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 11% volume in NY $16,265 industry payments

Medicare Practice Summary

Medicare Utilization ↗
27,876
Medicare services
Top 11% in NY for rheumatology
1,435
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,144 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 13,920 $19 $55
Romosozumab injection (Evenity) for osteoporosis 11,970 $8 $14
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
741 $111 $300
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
347 $13 $60
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
224 $77 $200
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
148 $1 $8
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
132 $145 $400
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
128 $46 $350
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
59 $95 $450
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
33 $62 $350
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
27 $1 $15
5% dextrose/water (500 ml = 1 unit) 27 $1 $15
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
25 $61 $175
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
20 $72 $80
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
20 $36 $40
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
19 $122 $400
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
18 $56 $200
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
18 $55 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
95.0% medium
4.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,265
Total received (2018-2024)
Avg $2,324/year across 7 years
Top 20% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
733
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,952 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,346
2023
$5,321
2022
$3,092
2021
$2,022
2020
$408
2019
$1,890
2018
$187

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$724
Janssen Biotech, Inc.
$476
UCB, Inc.
$441
ABBVIE INC.
$374
Lilly USA, LLC
$258
AstraZeneca Pharmaceuticals LP
$170
ANI Pharmaceuticals, Inc.
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$167
Novartis Pharmaceuticals Corporation
$140
GlaxoSmithKline, LLC.
$96
Radius Health, Inc.
$73
PFIZER INC.
$64
Kiniksa Pharmaceuticals International, plc
$54
Ferring Pharmaceuticals Inc.
$44
Mallinckrodt Hospital Products Inc.
$31
Fresenius Kabi USA, LLC
$29
Teva Pharmaceuticals USA, Inc.
$20
Aurinia Pharma U.S., Inc.
$17
Top 3 companies account for 49.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,780
AstraZeneca Pharmaceuticals LP
$1,810
Janssen Biotech, Inc.
$1,610
ABBVIE INC.
$1,405
Horizon Therapeutics plc
$1,161
UCB, Inc.
$1,094
Lilly USA, LLC
$931
PFIZER INC.
$604
Boehringer Ingelheim Pharmaceuticals, Inc.
$524
GlaxoSmithKline, LLC.
$439
Novartis Pharmaceuticals Corporation
$422
Mallinckrodt Hospital Products Inc.
$380
Regeneron Healthcare Solutions, Inc.
$358
AbbVie Inc.
$320
AbbVie, Inc.
$285
Genentech USA, Inc.
$276
Radius Health, Inc.
$269
ANI Pharmaceuticals, Inc.
$193
Ferring Pharmaceuticals Inc.
$168
Merck Sharp & Dohme Corporation
$162
E.R. Squibb & Sons, L.L.C.
$160
Horizon Pharma plc
$123
Aurinia Pharma U.S., Inc.
$123
Fresenius Kabi USA, LLC
$107
Alexion Pharmaceuticals, Inc.
$79
GENZYME CORPORATION
$63
Hikma Pharmaceuticals USA
$54
Kiniksa Pharmaceuticals International, plc
$54
Exeltis, USA Inc.
$45
Biohaven Pharmaceutical Holding Company Ltd.
$45
Zimmer Biomet Holdings, Inc.
$42
Pacira Pharmaceuticals Incorporated
$31
Kowa Pharmaceuticals America, Inc.
$29
MEDEXUS PHARMA, INC.
$29
Celgene Corporation
$22
Amarin Pharma Inc.
$20
Teva Pharmaceuticals USA, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$17
Shire North American Group Inc
$13
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · AccuFill · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSViTA · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · INFLECTRA · Iovera · JANUVIA · JARDIANCE · KEVZARA · KRYSTEXXA · LUPKYNIS · Livalo · Mitigare · NURTEC ODT · OFEV · OMVOH · ORENCIA · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SEGLENTIS · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · Vascepa · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Babylon?
Compare rheumatologists in the Babylon area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
94
Per 100K population
6.2
County median income
$128,329
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
3.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Haq is a mixed practice specialist, with above-average Medicare volume (top 11% in NY), with low-engagement industry engagement in the top 20% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Haq experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Haq performed 13,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haq receive payments from pharmaceutical companies?
Yes. Dr. Haq received a total of $16,265 from 39 companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haq's costs compare to other rheumatologists in Babylon?
Dr. Haq's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haq) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →